BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26853827)

  • 1. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
    Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
    Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
    Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3, alpha(v)beta3, and alpha5beta1 integrins.
    Calvete JJ; Fox JW; Agelan A; Niewiarowski S; Marcinkiewicz C
    Biochemistry; 2002 Feb; 41(6):2014-21. PubMed ID: 11827548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
    Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
    Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC5 and CC8, Two Disintegrin Isoforms from
    Morjen M; Zakraoui O; Abdelkafi-Koubaa Z; Srairi-Abid N; Marrakchi N; Essafi-Benkhadir K; Jebali J
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
    Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
    Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
    Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
    Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom.
    Allane D; Oussedik-Oumehdi H; Harrat Z; Seve M; Laraba-Djebari F
    J Biochem Mol Toxicol; 2018 Feb; 32(2):. PubMed ID: 29278277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
    Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
    Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
    Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
    Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FS145, the first flea-derived disintegrin, inhibits angiogenesis through specifically binding integrin α
    Lu W; Xiao Z; Liao H; Xie J; Gao Y; Xiong W; Zeng Q; Deng Z; Wu J; Chai J; Chen X; Xu X
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129289. PubMed ID: 38211910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viper venom components affecting angiogenesis.
    Huang TF; Yeh CH; Wu WB
    Haemostasis; 2001; 31(3-6):192-206. PubMed ID: 11910185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki.
    Lecht S; Chiaverelli RA; Gerstenhaber J; Calvete JJ; Lazarovici P; Casewell NR; Harrison R; Lelkes PI; Marcinkiewicz C
    Biochim Biophys Acta; 2015 Jun; 1850(6):1169-79. PubMed ID: 25665484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo.
    Kessentini-Zouari R; Jebali J; Taboubi S; Srairi-Abid N; Morjen M; Kallech-Ziri O; Bezzine S; Marvaldi J; El Ayeb M; Marrakchi N; Luis J
    Lab Invest; 2010 Apr; 90(4):510-9. PubMed ID: 20142800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
    Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
    Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
    Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
    Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.
    Calvete JJ; Marcinkiewicz C; Sanz L
    Curr Pharm Des; 2007; 13(28):2853-9. PubMed ID: 17979730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disintegrins extracted from totonacan rattlesnake (Crotalus totonacus) venom and their anti-adhesive and anti-migration effects on MDA-MB-231 and HMEC-1 cells.
    Rivas Mercado E; Neri Castro E; Bénard Valle M; Rucavado-Romero A; Olvera Rodríguez A; Zamudio Zuñiga F; Alagón Cano A; Garza Ocañas L
    Toxicol In Vitro; 2020 Jun; 65():104809. PubMed ID: 32087267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
    Ren X; Dai M; Lin LP; Li PK; Ding J
    Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.